Found 4 matching trials
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder PHASE3 The study is intended to test the safety, tolerability, efficacy of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication. PHASE4 To evaluate the effect of tolterodine ER in conjunction with behavioral int...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction PHASE4 The primary objective of the trial is to evaluate the effect of tolterodine...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. PHASE3 To evaluate the efficacy and safety of fesoterodine in comparison to tolter...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial